Spikevax bivalent origineel/omicron BA.1 (25 microgram/25 microgram) dispersie voor injectie

{
  "form": "Dispersie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/spikevax-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Covid-19, RNA-based vaccine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp131103",
  "excipients": [
    "1,2-DIMYRISTOYL-RAC-GLYCERO-3-METHOXYPOLYETHYLEENGLYCOL-2000",
    "1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE",
    "AZIJNZUUR (E 260)",
    "CHOLESTEROL",
    "HEPTADECAAN-9-YL 8-((2-HYDROXYETHYL)(6-OXO-6-(UNDECYLOXY) HEXYL) AMINO) OCTANOAAT",
    "NATRIUMACETAAT 3-WATER (E 262)",
    "SACCHAROSE",
    "TROMETAMOL",
    "TROMETAMOLHYDROCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "ELASOMERAN",
    "IMELASOMERAN"
  ],
  "leaflet_url": null,
  "authorised_at": "2021/01/06",
  "procedure_number": "EMEA/H/C/005791",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/20/1507",
  "additional_monitoring": "Y"
}